Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier.
D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D007939:Leukemia L1210 / Q000188:drug therapy / Q000276:immunology; D007941:Leukemia P388 / Q000188:drug therapy / Q000276:immunology; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D008264:Macrophages / Q000276:immunology; D008545:Melanoma / Q000188:drug therapy / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008811:Mice, Inbred DBA; D009368:Neoplasm Transplantation; D009504:Neutrophils / Q000276:immunology; D010587:Phagocytosis; D011956:Receptors, Cell Surface / Q000276:immunology; D011971:Receptors, Immunologic; D014405:Tuftsin / Q000276:immunology* / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use
D011956:Receptors, Cell Surface; D011971:Receptors, Immunologic; C029695:tuftsin receptor; D014405:Tuftsin